Developed by the Patient Advisory Group, specialists in the cholestatic liver diseases primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) collaborate with patient advocates to shine a light on: (1) newly available treatments for PBC; (2) a new tool for patients to use during their first visit with their hepatologist; (3) an exciting registry for patients with PSC; and (4) what patients need to know about symptom management. 

This interactive, joint AASLD and Society on Liver Disease in Africa (SOLDA) community conversation explores the global epidemiology of DILI and regional differences in its etiology. Needs associated with DILI and associated registries are identified. Through case presentations, panelists illustrate unique features of etiologies of DILI in Africa and highlight differences in diagnostic strategies and management. Presenters also review DILI survey data from Africa and identify DILI-related research gaps. The session aims to formulate strategies to overcome DILI managment challenges and advance DILI-related research in Africa. 

Join us for a poster highlight of the top abstracts from the Liver Transplantation and Surgery (LT&S) SIG. 
 

Continuing the successful AASLD-KASL collaboration underway since 2023, this session highlights practice-changing innovations in hepatology from leading researchers in the U.S. and Korea. Topics include the application of artificial intelligence for non-invasive assessment of liver fibrosis in patients with MASLD, the use of speech pattern analysis as a digital biomarker for detecting hepatic encephalopathy, clinical data on autologous bone marrow-derived mesenchymal stem cell transplantation for liver cirrhosis, and AI-powered tools that synthesize clinical guidelines to support real-time decision-making. A panel discussion will follow to explore the clinical impact, implementation challenges, and global relevance of these emerging technologies.

Join us for a poster highlight of the top abstracts from the Pediatric Liver Disorders (PLD) SIG. 
 

Join us for a poster highlight of the top abstracts from the Liver Fibrosis SIG. 
 

This session on alcohol-associated liver disease (ALD) provides a comprehensive overview from both patient and physician perspectives, emphasizing early detection, equitable access to treatment, and inclusive research practices. The session includes a patient sharing their experiences, highlighting the physical and emotional challenges of living with ALD and the importance of support systems. Physicians discuss early detection, detailing diagnostic tools and the benefits of early intervention. They also address how disparities influence access to liver transplantation and clinical trial opportunities, and propose strategies that center on equity. After the individual presentations, a panel of speakers answer questions from the audience and engage in a dialogue about the future directions in ALD detection, treatment, and research. 

Developed by the Patient Advisory Group, this session focuses on types of palliative care throughout various stages of liver disease, and how palliative care can be helpful for both patients with liver disease and their caregivers.

Join us for a poster highlight of the top abstracts from the MASLD SIG.